Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker XRAY
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Clyde Hosein Director | XRAY DENTSPLY SIRONA Inc. | Buy | 6,500 | $9.99 | $64.9K Buy | Form 4 ↗ |
| Jun 15, 2026 | Brian T. Gladden Director | XRAY DENTSPLY SIRONA Inc. | Buy | 9,985 | $10.02 | $100.0K Buy | Form 4 ↗ |
| Jun 12, 2026 | Jonathan Jay Mazelsky Director | XRAY DENTSPLY SIRONA Inc. | Buy | 10,000 | $10.14 | $101.4K Buy | Form 4/A ↗ |
| Jun 12, 2026 | Brian P. McKeon Director | XRAY DENTSPLY SIRONA Inc. | Buy | 10,000 | $10.12 | $101.2K Buy | Form 4 ↗ |
| Jun 11, 2026 | Betsy D. Holden Director | XRAY DENTSPLY SIRONA Inc. | Buy | 10,086 | $9.88 | $99.6K Buy | Form 4 ↗ |
| Jun 11, 2026 | Michael J. Barber Director | XRAY DENTSPLY SIRONA Inc. | Buy | 15,175 | $9.89 | $150.1K Buy | Form 4 ↗ |
| Mar 9, 2026 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 15,000 | $12.45 | $186.8K Buy | Form 4 ↗ |
| Mar 9, 2026 | James D. Forbes Director | XRAY DENTSPLY SIRONA Inc. | Buy | 5,000 | $12.48 | $62.4K Buy | Form 4 ↗ |
| Mar 3, 2026 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 22,445 | $14.03 | $314.9K Buy | Form 4 ↗ |
| Mar 3, 2026 | James D. Forbes Director | XRAY DENTSPLY SIRONA Inc. | Buy | 5,000 | $13.47 | $67.3K Buy | Form 4 ↗ |
| Mar 2, 2026 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 27,555 | $14.25 | $392.7K Buy | Form 4 ↗ |
| Dec 8, 2025 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Sale | 82,200 | $11.14 | $915.7K Sale | Form 4 ↗ |
| Nov 24, 2025 | Leslie F. Varon Director | XRAY DENTSPLY SIRONA Inc. | Buy | 9,337 | $10.71 | $100.0K Buy | Form 4 ↗ |
| Mar 3, 2025 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 15,142 | $16.51 | $250.0K Buy | Form 4 ↗ |
| Nov 18, 2024 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 5,000 | $18.37 | $91.8K Buy | Form 4/A ↗ |
| Nov 15, 2024 | Gregory T. Lucier Director | XRAY DENTSPLY SIRONA Inc. | Buy | 1,000 | $18.28 | $18.3K Buy | Form 4/A ↗ |
| Nov 12, 2024 | Simon D. Campion President, CEO & Member of BOD, Director | XRAY DENTSPLY SIRONA Inc. | Buy | 11,306 | $17.72 | $200.3K Buy | Form 4 ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances